Abeona Therapeutics (ABEO) Asset Utilization Ratio (2011 - 2026)

Abeona Therapeutics' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.07 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.07 in Q1 2026; TTM through Mar 2026 was 0.07, a N/A change from a year earlier, with the FY2025 full-year figure at 0.04, changed N/A from the prior year.
• Asset Utilization Ratio climbed to 0.07 in Q1 2026 per ABEO's latest filing, from 0.03 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.23 in Q2 2022 and bottomed at 0.0 in Q3 2025.
• The 5-year median for Asset Utilization Ratio is 0.05 (2023), against an average of 0.07.
• Across the five-year window, Asset Utilization Ratio tumbled 88.17% in 2023 and jumped 177.5% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.03 in 2022, then soared by 95.93% to 0.05 in 2023, then decreased by 6.3% to 0.05 in 2024, then sank by 48.77% to 0.03 in 2025, then surged by 169.31% to 0.07 in 2026.
• Per Business Quant, the three latest ABEO Asset Utilization Ratio figures stand at 0.07 (Q1 2026), 0.03 (Q4 2025), and 0.0 (Q3 2025).